Researchers at the Netherlands Institute for Neuroscience have found evidence that type-1 narcolepsy, a condition known for ...

New research links narcolepsy to an autoimmune attack on brain cells, explaining sudden sleep episodes and opening doors to ...

Social media is awash with chemical compounds you can’t pronounce promising the world. When it comes to self-dosing mushrooms ...

Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold for the next 3 years. On March 31, Eli Lilly ...

The deal secures two sleep disorder drugs that would fill a hole in the company’s portfolio and intensify a competition with ...

Alkermes plc (Nasdaq: ALKS) today announced the initiation of the Brilliance Studies, a phase 3 program evaluating the safety ...

By Sneha S K March 31 (Reuters) - Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal valued at up to ...

Indianapolis-based Eli Lilly and Co. announced plans to acquire UK-based Centessa Pharmaceuticals in a deal worth up to $7.8 ...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...

Brain lesions in Down syndrome aren’t always permanent. The vascular changes can fluctuate or even decrease over time as ...

Millions of people start work before sunrise—but their brains aren’t ready for it. A new clinical trial has found that the ...